Bimetallic Copper–Manganese Zeolitic Imidazolate Framework Nanozyme Scavenges Reactive Oxygen Species to Alleviate Osteoarthritis via Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Axis and Autophagic Flux Restoration
Biomaterials Research · 2026-01 · 30
DOI: 10.34133/bmr.0306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 21.01.2026. Verfasst von Xiaoyu Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin 150001, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Science foundation of Health Commission of Heilongjiang Province, Outstanding Medical Fund for Young Scholar of the First Affiliated Hospital of Harbin Medical University.
Abstract (Originalsprache)
Osteoarthritis (OA) is the fastest-growing cause of physical disability worldwide, yet no therapy currently halts its age-dependent progression. Increasing evidence suggests that reactive oxygen species (ROS) are central drivers of cartilage degradation and OA progression. Therefore, the clearance of ROS is critical for mitigating OA progression and developing effective therapeutic strategies. In this study, we report a bioinspired copper–manganese zeolitic imidazolate framework (CuMn-ZIF) that integrates catalase (CAT) and superoxide dismutase (SOD)-mimetic activities within a single nanoplatform. By simultaneously scavenging H 2 O 2 and superoxide anions, the CuMn-ZIF nanozyme rebalances redox status in human OA chondrocytes, suppressing PI3K–AKT–mTOR signaling and restoring lysosomal–autophagic flux. An intra-articular injection in destabilized medial meniscus (DMM) mice markedly ameliorated cartilage deterioration and subchondral bone loss, showing a 1.5-fold increase in bone mineral density (BMD), a 2.1-fold greater bone volume/tissue volume (BV/TV), and a 2-fold increase in trabecular number compared to DMM controls. Comprehensive in vitro and in vivo analyses validated the CuMn-ZIF nanozyme as a potent therapeutic agent, demonstrating exceptional catalytic activity and reproducible disease-modifying effects in OA. This work establishes a scalable blueprint for ROS-targeting, enzyme-mimetic nanomedicines that can potentially be translated to treat OA and other ROS-dependent diseases.
Autor:innen und Institutionen
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin 150001, China.
- Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin 150001, China.
- Department of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
- Harbin Medical University, Harbin 150001, China.
- NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC); Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Harbin 150028, China.
ORCID-Profile: Tianqi Dai
Förderung
- National Natural Science Foundation of China
- Science foundation of Health Commission of Heilongjiang Province
- Outstanding Medical Fund for Young Scholar of the First Affiliated Hospital of Harbin Medical University
- Haiyan Foundation of Harbin Medical University Cancer Hospital
- 2023 Fundamental Research Funds for the Provincial Universities
- Haiyan Research Fund youth project
Zitieren
APA
Zheng, X., Zhao, S., Li, S., Wang, Y., Shi, J., Qiu, Y., Wu, X., Zhao, Y., Jia, T., & Dai, T. (2026). Bimetallic Copper–Manganese Zeolitic Imidazolate Framework Nanozyme Scavenges Reactive Oxygen Species to Alleviate Osteoarthritis via Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Axis and Autophagic Flux Restoration. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0306
Vancouver
Zheng X, Zhao S, Li S, Wang Y, Shi J, Qiu Y, et al. Bimetallic Copper–Manganese Zeolitic Imidazolate Framework Nanozyme Scavenges Reactive Oxygen Species to Alleviate Osteoarthritis via Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Axis and Autophagic Flux Restoration. Biomaterials Research. 2026;30. doi:10.34133/bmr.0306
BibTeX
@article{Zheng2026,
author = {Zheng, Xiaoyu and Zhao, Su and Li, Shuming and Wang, Yanli and Shi, Jiani and Qiu, Yufei and Wu, Xutong and Zhao, Yanping and Jia, Tao and Dai, Tianqi},
title = {Bimetallic Copper–Manganese Zeolitic Imidazolate Framework Nanozyme Scavenges Reactive Oxygen Species to Alleviate Osteoarthritis via Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Axis and Autophagic Flux Restoration},
journal = {Biomaterials Research},
year = {2026},
volume = {30},
doi = {10.34133/bmr.0306}
}
EUVIMED